Pramlintide
Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 184
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.